677 related articles for article (PubMed ID: 7884953)
1. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
Small GW; Mazziotta JC; Collins MT; Baxter LR; Phelps ME; Mandelkern MA; Kaplan A; La Rue A; Adamson CF; Chang L
JAMA; 1995 Mar 22-29; 273(12):942-7. PubMed ID: 7884953
[TBL] [Abstract][Full Text] [Related]
2. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes.
Corder EH; Jelic V; Basun H; Lannfelt L; Valind S; Winblad B; Nordberg A
Arch Neurol; 1997 Mar; 54(3):273-7. PubMed ID: 9074396
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.
Reiman EM; Caselli RJ; Yun LS; Chen K; Bandy D; Minoshima S; Thibodeau SN; Osborne D
N Engl J Med; 1996 Mar; 334(12):752-8. PubMed ID: 8592548
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
Li G; Silverman JM; Altstiel LD; Haroutunian V; Perl DP; Purohit D; Birstein S; Lantz M; Mohs RC; Davis KL
Genet Epidemiol; 1996; 13(3):285-98. PubMed ID: 8797010
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
6. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
Lee KU; Lee JS; Kim KW; Jhoo JH; Lee DY; Yoon JC; Lee JH; Lee DS; Lee MC; Woo JI
J Neuropsychiatry Clin Neurosci; 2003; 15(1):78-83. PubMed ID: 12556576
[TBL] [Abstract][Full Text] [Related]
7. Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer disease.
Ercoli L; Siddarth P; Huang SC; Miller K; Bookheimer SY; Wright BC; Phelps ME; Small G
Arch Gen Psychiatry; 2006 Apr; 63(4):442-8. PubMed ID: 16585474
[TBL] [Abstract][Full Text] [Related]
8. Lack of association of apolipoprotein E epsilon4 allele dose with cerebral glucose metabolism in Alzheimer disease.
Hirono N; Mori E; Yasuda M; Ishii K; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Sasaki M
Alzheimer Dis Assoc Disord; 1998 Dec; 12(4):362-7. PubMed ID: 9876966
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotype in patients with Alzheimer's disease: implications for the risk of dementia among relatives.
Farrer LA; Cupples LA; van Duijn CM; Kurz A; Zimmer R; Müller U; Green RC; Clarke V; Shoffner J; Wallace DC
Ann Neurol; 1995 Nov; 38(5):797-808. PubMed ID: 7486872
[TBL] [Abstract][Full Text] [Related]
10. Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.
Small GW
J Clin Psychiatry; 1996; 57 Suppl 14():9-13. PubMed ID: 9024331
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.
Dal Forno G; Rasmusson DX; Brandt J; Carson KA; Brookmeyer R; Troncoso J; Kawas CH
Arch Neurol; 1996 Apr; 53(4):345-50. PubMed ID: 8929157
[TBL] [Abstract][Full Text] [Related]
12. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
13. Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.
Mosconi L; Herholz K; Prohovnik I; Nacmias B; De Cristofaro MT; Fayyaz M; Bracco L; Sorbi S; Pupi A
J Neurol Neurosurg Psychiatry; 2005 Jan; 76(1):15-23. PubMed ID: 15607989
[TBL] [Abstract][Full Text] [Related]
14. Absence of an apolipoprotein E epsilon4 allele is associated with increased parietal regional cerebral blood flow asymmetry in Alzheimer disease.
van Dyck CH; Gelernter J; MacAvoy MG; Avery RA; Criden M; Okereke O; Varma P; Seibyl JP; Hoffer PB
Arch Neurol; 1998 Nov; 55(11):1460-6. PubMed ID: 9823831
[TBL] [Abstract][Full Text] [Related]
15. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
16. Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease.
Mosconi L; Nacmias B; Sorbi S; De Cristofaro MT; Fayazz M; Tedde A; Bracco L; Herholz K; Pupi A
J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):370-6. PubMed ID: 14966149
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.
Yasuda M; Mori E; Kitagaki H; Yamashita H; Hirono N; Shimada K; Maeda K; Tanaka C
Am J Psychiatry; 1998 Jun; 155(6):779-84. PubMed ID: 9619150
[TBL] [Abstract][Full Text] [Related]
18. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
[TBL] [Abstract][Full Text] [Related]
19. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease.
Small GW; Ercoli LM; Silverman DH; Huang SC; Komo S; Bookheimer SY; Lavretsky H; Miller K; Siddarth P; Rasgon NL; Mazziotta JC; Saxena S; Wu HM; Mega MS; Cummings JL; Saunders AM; Pericak-Vance MA; Roses AD; Barrio JR; Phelps ME
Proc Natl Acad Sci U S A; 2000 May; 97(11):6037-42. PubMed ID: 10811879
[TBL] [Abstract][Full Text] [Related]
20. Cerebral glucose metabolism in patients with AD and different APOE genotypes.
Drzezga A; Riemenschneider M; Strassner B; Grimmer T; Peller M; Knoll A; Wagenpfeil S; Minoshima S; Schwaiger M; Kurz A
Neurology; 2005 Jan; 64(1):102-7. PubMed ID: 15642911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]